In win for generic drug firms, Federal Court upholds Health Canada’s patent listing policy
The Federal Court has upheld Health Canada's decision not to retroactively change the listing date of a patent to its submission date, highlighting that patents are only added to the patent...To view the full article, register now.
Already a subscriber? Click here to view full article